Guillain-Barre syndrome in Pakistan: similarity of demyelinating and axonal variants

被引:30
|
作者
Shafqat, S [1 ]
Khealani, BA [1 ]
Awan, F [1 ]
Abedin, SE [1 ]
机构
[1] Aga Khan Univ, Coll Med, Dept Med, Neurol Sect, Karachi 74800, Pakistan
关键词
Campylobacter jejuni; cerebrospinal fluid; functional outcome;
D O I
10.1111/j.1468-1331.2006.01071.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Guillain-Barre syndrome (GBS) comprises multiple subtypes whose nosological and pathophysiologic interrelationships are unclear. In an attempt to better understand the relationship between the disease's major subtypes, we reviewed the characteristics of GBS cases consecutively admitted to a tertiary care hospital in Karachi, Pakistan, over a 13-year period. Of 175 cases, 80 (46%) were demyelinating and 55 (31%) axonal, whilst 40 (23%) had ambiguous electrophysiological findings precluding classification. The three groups differed in severity of weakness at presentation (axonal similar to ambiguous > demyelinating; P = 0.002 for arm strength and P = 0.025 for leg strength); mean age (demyelinating > axonal > ambiguous; P = 0.05); and mean cerebrospinal fluid protein concentration (demyelinating > ambiguous > axonal; P = 0.05). However, they were similar in several other respects, including gender ratio, proportion of pediatric cases, history of antecedent infection, length of hospital stay, need and duration of mechanical ventilation, and functional outcome at discharge. Stool culture data was available for 146 (83%) cases in the study; none was positive for Campylobacter jejuni. GBS in Pakistan comprises a high proportion of axonal cases. Similarity of outcomes in axonal and demyelinating variants and lack of C. jejuni stool culture positivity are atypical features.
引用
收藏
页码:662 / 665
页数:4
相关论文
共 50 条
  • [41] Axonal forms of Guillain-Barre syndrome: Evidence of immunopathogenesis
    Griffin, JW
    Li, CY
    Ho, TW
    Cornblath, DR
    McKhann, GM
    Asbury, AK
    NEUROLOGY, 1996, 46 (02) : 37006 - 37006
  • [42] Prediction of Functional Outcome in Axonal Guillain-Barre Syndrome
    Sung, Eun Jung
    Kim, Dae Yul
    Chang, Min Cheol
    Ko, Eun Jae
    ANNALS OF REHABILITATION MEDICINE-ARM, 2016, 40 (03): : 481 - 488
  • [43] Axonal pathology in early stages of Guillain-Barre syndrome
    Berciano, J.
    NEUROLOGIA, 2022, 37 (06): : 466 - 479
  • [44] Hyperreflexia in a patient with motor axonal Guillain-Barre syndrome
    Podnar, S
    Vodusek, DB
    EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 (06) : 727 - 730
  • [45] Axonal Guillain-Barre syndrome: carbohydrate mimicry and pathophysiology
    Yuki, Nobuhiro
    Kuwabara, Satoshi
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 (04) : 238 - 249
  • [46] Neuromuscular transmission is not impaired in axonal Guillain-Barre syndrome
    Kuwabara, S.
    Kokubun, N.
    Misawa, S.
    Kanai, K.
    Isose, S.
    Shibuya, K.
    Noto, Y.
    Mori, M.
    Sekiguchi, Y.
    Nasu, S.
    Fujimaki, Y.
    Hirata, K.
    Yuki, N.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (10): : 1174 - 1177
  • [47] CASE OF CHRONIC DEMYELINATING POLYNEUROPATHY RESEMBLING GUILLAIN-BARRE SYNDROME
    TORVIK, A
    LUNDAR, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1977, 32 (01) : 45 - 52
  • [48] CSF neurofilament protein levels predict the primary pathology (axonal versus demyelinating) in Guillain-Barre syndrome
    Petzold, A
    Hinds, N
    Keir, G
    Thompson, EJ
    Chapman, M
    Murrray, N
    Hirsch, N
    Manji, H
    Reilly, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S119 - S119
  • [49] Study of total duration of distal compound muscle action potential in demyelinating and axonal Guillain-Barre' syndrome
    Ginanneschi, Federica
    Cioncoloni, David
    Capoccitti, Giorgio
    Volpi, Nila
    Ferretti, Fabio
    Giannini, Fabio
    Rossi, Alessandro
    NEUROLOGICAL RESEARCH, 2023, 45 (04) : 381 - 389
  • [50] Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome.
    Ho, TW
    Willison, HJ
    Nachamkin, I
    Li, CY
    Veitch, J
    Ung, H
    Wang, GR
    Liu, RC
    Cornblath, DR
    Asbury, AK
    Griffin, JW
    McKhann, GM
    ANNALS OF NEUROLOGY, 1999, 45 (02) : 168 - 173